Clinical Trial Update: Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing basal insulins detemir and glargine in type 2 diabetes, focusing on weight gain, eating patterns, and body composition during initiation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Levemir (insulin detemir)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Diabetes, Obesity | Phase 3 | Status: TERMINATED